Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. - Test2 - elhamkhani - TriplyDB

Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway.

Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway.

http://www.wikidata.org/entity/Q36135658

about

The Relationship between Metabolic Syndrome and Osteoporosis: A Review SerpinB1 Promotes Pancreatic β Cell Proliferation Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.Diabetes, bone and glucose-lowering agents: basic biology.Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion Inter-organ communication and regulation of beta cell function IRS1 deficiency protects β-cells against ER stress-induced apoptosis by modulating sXBP-1 stability and protein translation.Critical role for adenosine receptor A2a in β-cell proliferation.A Pdx-1-Regulated Soluble Factor Activates Rat and Human Islet Cell Proliferation.Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes.Exploring inter-organ crosstalk to uncover mechanisms that regulate β-cell function and mass.Insulin Signaling Regulates the FoxM1/PLK1/CENP-A Pathway to Promote Adaptive Pancreatic β Cell Proliferation.Novel factors modulating human β-cell proliferation.Advances in β cell replacement and regeneration strategies for treating diabetes Bone Cell Bioenergetics and Skeletal Energy Homeostasis.Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity.Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems.Modeling human pancreatic beta cell dedifferentiation.(Re)generating Human Beta Cells: Status, Pitfalls, and Perspectives.Age-related islet inflammation marks the proliferative decline of pancreatic beta-cells in zebrafish.Heterogeneity of proliferative markers in pancreatic β-cells of patients with severe hypoglycemia following Roux-en-Y gastric bypass.Role of the NFκB-signaling pathway in cancer.GAG and collagen II attenuate glucocorticoid-induced osteoporosis by regulating NF-κB and MAPK signaling.Inhibition of TBK1/IKKε Promotes Regeneration of Pancreatic β-cells Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus

P2860

Q26747451-6979673D-955D-4933-A02E-7E90E4A2B21D Q30354433-05FAE961-72DC-4B8C-8C96-0552825ED22E Q33692037-6984BD29-9314-4B5B-94D0-A8E5FDED2388 Q33843692-F82E395F-3045-478B-94CE-FF926C9F025B Q35890262-9B36570C-5F4B-405D-A7AC-4BD12398134D Q36709997-12BE988C-7D38-4B4C-935E-969F941D5451 Q37063923-B35726C4-A229-4610-A597-B0DC6E794369 Q37368761-66B71D82-8D64-42B0-9228-CB8C7BDECE34 Q37413659-2EE08FD2-6CCB-4BD9-BD85-443089320215 Q37641079-88B0EB63-DE1D-4E6F-A7D6-BE062559C65D Q38907710-F52AE685-CDCB-4299-969A-31BDBE52545F Q38912442-566FB39A-9ABE-40EE-8BF9-A5E9FA2AAF52 Q38951158-AADDA4A0-B599-464A-BD37-D45F6FCC9B7A Q38970248-546D9A03-0F91-42E2-8AC4-6299F4B090C9 Q39137277-BC3777A3-25FE-4E50-A465-C61BDF9CFC7D Q42003109-B1319462-4799-4653-9E58-9D40FE48F93B Q47944184-88275F8C-00DD-47B5-B1F3-952CAB6AB186 Q52689330-68BB587B-9C2A-4BA3-925A-4D5E92380B3B Q52714852-77BC79E7-1DD1-4355-8213-A883A346BFFB Q52721177-9E86E25B-6F4D-4F66-89E1-D6BFC940086C Q52770258-E4B8FB21-2B44-4DBE-BF97-FB5A3E53CFE4 Q55092578-144D5400-EA7B-4CCB-A5BB-10168A18F012 Q55714899-346ABF3C-24BE-4B2C-AC20-EF4E357C27F8 Q57805706-5868EDD9-69AC-4638-B3A1-4B5F5D36A6ED Q58805499-6BB0D9AC-ACB7-460A-B754-08987E3F8992

P2860

Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway.

http://www.wikidata.org/entity/Q36135658

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Osteoprotegerin and Denosumab ...... vator of NF-κB Ligand Pathway.

@ast

Osteoprotegerin and Denosumab ...... vator of NF-κB Ligand Pathway.

@en

type

label

Osteoprotegerin and Denosumab ...... vator of NF-κB Ligand Pathway.

@ast

Osteoprotegerin and Denosumab ...... vator of NF-κB Ligand Pathway.

@en

prefLabel

Osteoprotegerin and Denosumab ...... vator of NF-κB Ligand Pathway.

@ast

Osteoprotegerin and Denosumab ...... vator of NF-κB Ligand Pathway.

@en

P1433

Q36135658-05D76418-9E15-4FA8-9FCD-1F60355384A6

P1476

Q36135658-64F094DD-2D7B-45A3-BC82-94252BFAB17D

P2093

Q36135658-097EAF33-1AB8-4D83-B23D-93267028AF80

Q36135658-265CF192-4714-4A7E-8CF6-CCE08C48782F

Q36135658-2D718661-9652-42A8-B79C-97A9676DE3D0

Q36135658-5E0407E5-7758-456C-A926-74227856B412

Q36135658-628C6FEF-012F-41E2-8EF8-EEA5863D0223

Q36135658-AEDFFA53-91D4-4CAC-8024-6FAB1AE7CA41

P2860

Q36135658-010FF9B3-89C3-4648-8FDA-4BC42CED08D9

Q36135658-07D518CC-E921-43D3-ABE9-BFAAC1261B8D

Q36135658-13B3AF3C-D697-4687-9E11-314ADACA65E5

Q36135658-1D4E99E9-A1D8-42F9-A2C5-5F7C72B57649

Q36135658-2BAE131E-DBBB-4F87-B1D2-24D67C185EF9

Q36135658-2CE49202-71B9-45D9-BDCD-49E580A4F468

Q36135658-2FFBA2AB-A98F-49EC-AA0C-77FC76059F6C

Q36135658-30EFD765-A002-4022-8431-53884122B42B

Q36135658-37226073-188F-47E4-B7DE-9A1A92F43864

Q36135658-37740BAA-2B83-46C4-9FF3-945F117D50F7

P304

Q36135658-F36AAF76-64FA-4695-8CB0-5100EFD9A1FE

P31

Q36135658-73B10C7B-1903-4986-AE1B-A02AB6415D20

P356

Q36135658-D50A54EF-35D6-4F03-A863-9645EE001BC4

P433

Q36135658-C9607C30-040E-4AD8-9D58-6E269CC318AE

P478

Q36135658-ED5AFD06-2B50-49FB-B71C-0FF94417CD36

P50

Q36135658-01B906BD-22E2-4F91-A0BE-21E9966C32E7

P577

Q36135658-881E103E-8A15-4F03-9B2F-B8EC924533DD

P698

Q36135658-1C89A17F-E39F-4DF8-B385-90EB93C0271F

P921

Q36135658-FD190048-755E-415C-AFF3-7F2B705D0068

P932

Q36135658-0F0299AD-BFEA-4F8B-B3F4-E4E6A2FC6FC4

P356

J.CMET.2015.05.021

P1433

Cell Metabolism

P1476

Osteoprotegerin and Denosumab ...... vator of NF-κB Ligand Pathway.

@en

P2093

Adolfo Garcia-Ocaña

http://www.w3.org/2001/XMLSchema#string

Ilana R Pollack

http://www.w3.org/2001/XMLSchema#string

Michael Orthofer

http://www.w3.org/2001/XMLSchema#string

Nagesha Guthalu Kondegowda

http://www.w3.org/2001/XMLSchema#string

Rafael Fenutria

http://www.w3.org/2001/XMLSchema#string

Rupangi C Vasavada

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Denosumab: anti-RANKL antibody

Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulation

Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Janus kinase-2 (JAK2)/signal transducer and activator of transcription-5 (STAT5) signalling

Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating

Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation

Detailed transcriptome atlas of the pancreatic beta cell

Maternal plasma osteoprotegerin concentration in normal pregnancy

Increased pancreatic beta-cell proliferation mediated by CREB binding protein gene activation

Human β-cell proliferation and intracellular signaling: driving in the dark without a road map.

P304

77-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CMET.2015.05.021

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Josef M Penninger

P577

2015-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26094891

http://www.w3.org/2001/XMLSchema#string

P921

P932

4597781

http://www.w3.org/2001/XMLSchema#string